Opiate abuse, innate immunity, and bacterial infectious diseases

被引:0
|
作者
Jinghua Wang
Roderick A. Barke
Jing Ma
Richard Charboneau
Sabita Roy
机构
[1] University of Minnesota,Division of Basic and Translational Research, Department of Surgery
[2] Veterans Affairs Medical Center,Department of Surgery
[3] Jilin University Norman Bethune Medical College,Department of Immunology
[4] University of Minnesota,Department of Pharmacology
关键词
opiate; morphine; innate immunity; macrophages; neutrophils; dentritic cells; NK cells; γδ T lymphocytes; cytokines; bacterial infection;
D O I
暂无
中图分类号
学科分类号
摘要
The first line of defense against invading bacteria is provided by the innate immune system. Morphine and other opiates can immediately disrupt the body’s first line of defense against harmful external bacteria. Opiate, for example morphine, abuse degrades physical and physiologic barriers, and modulates phagocytic cells (macrophages, neutrophils) and, nonspecific cytotoxic T cells (γδ T), natural killer cells, and dendritic cells, that are functionally important for carrying out a rapid immune reaction to invading pathogens. In vitro studies with innate immune cells from experimental animals and humans and in vivo studies with animal models have shown that opiate abuse impairs innate immunity and is responsible for increased susceptibility to bacterial infection. However, to better understand the complex interactions between opiates, innate immunity, and bacterial infection and develop novel approaches to treat and even prevent bacterial infection in the opiate-abuse population, there is an urgent need to fill the numerous gaps in our understanding of the cellular and molecular mechanisms by which opiate abuse increases susceptibility to bacterial infection.
引用
收藏
页码:299 / 309
页数:10
相关论文
共 50 条
  • [1] Opiate abuse, innate immunity, and bacterial infectious diseases
    Wang, Jinghua
    Barke, Roderick A.
    Ma, Jing
    Charboneau, Richard
    Roy, Sabita
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2008, 56 (05) : 299 - 309
  • [2] Trained Innate Immunity in Pediatric Infectious Diseases
    Lajqi, Trim
    Koestlin-Gille, Natascha
    Gille, Christian
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2024, 43 (02) : e57 - e59
  • [3] Antimicrobial peptides in the innate immunity of infectious diseases.
    Rivas-Santiago, B
    Sada, E
    Hernández-Pando, R
    Tsutsumi, V
    SALUD PUBLICA DE MEXICO, 2006, 48 (01): : 62 - 71
  • [4] Innate immunity against infectious diseases, particularly in swine
    Pejsak, Zygmunt
    Truszczynski, Marian
    Tarasiuk, Kazimierz
    MEDYCYNA WETERYNARYJNA-VETERINARY MEDICINE-SCIENCE AND PRACTICE, 2020, 76 (02): : 67 - 70
  • [5] New Biomarkers of Innate and Adaptive Immunity in Infectious Diseases
    Morzunov, Sergey
    Deyde, Varough
    Abrahamyan, Levon
    JOURNAL OF IMMUNOLOGY RESEARCH, 2017, 2017
  • [6] In this issue: Innate immunity and infectious diseases-An update
    Kumar, Himanshu
    Bot, Adrian
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2017, 36 (02) : 55 - 56
  • [7] Adaptive and innate immunity in patients with intracranial infectious and inflammatory diseases
    Sautin, M.
    Bodrova, T.
    Cherepakhina, N.
    Suchkov, S.
    IMMUNOLOGY, 2012, 137 : 667 - 667
  • [8] Vitamin D signaling, infectious diseases, and regulation of innate immunity
    White, John H.
    INFECTION AND IMMUNITY, 2008, 76 (09) : 3837 - 3843
  • [9] Toll-like receptors in innate immunity and infectious diseases
    Wu M.-H.
    Zhang P.
    Huang X.
    Frontiers of Medicine in China, 2010, 4 (4): : 385 - 393
  • [10] Role of stomata in plant innate immunity and foliar bacterial diseases
    Melotto, Maeli
    Underwood, William
    He, Sheng Yang
    ANNUAL REVIEW OF PHYTOPATHOLOGY, 2008, 46 : 101 - 122